superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2018-03-31
- Valid until
- 2018-06-30
- Published
- 2018-05-03
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 551,412,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals quarterly net income: 477,980,000 United States dollar", as of 2018-03-31 (until 2018-06-30). Claim clm_8ABE9095142D, https://asof.is/claim/clm_8ABE9095142D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217618000020/0001532176-18-000020-index.htm.
APA
AsOf. (2018). Regeneron Pharmaceuticals quarterly net income: 477,980,000 United States dollar (as of 2018-03-31 (until 2018-06-30)) [Record clm_8ABE9095142D]. Retrieved November 9, 2026, from https://asof.is/claim/clm_8ABE9095142D (source: https://www.sec.gov/Archives/edgar/data/872589/000153217618000020/0001532176-18-000020-index.htm)
BibTeX
@misc{asof_clm_8ABE9095142D,
author = {AsOf},
title = {Regeneron Pharmaceuticals quarterly net income: 477,980,000 United States dollar},
year = {2018},
howpublished = {\url{https://asof.is/claim/clm_8ABE9095142D}},
note = {Claim clm\_8ABE9095142D, as of 2018-03-31 (until 2018-06-30); source: https://www.sec.gov/Archives/edgar/data/872589/000153217618000020/0001532176-18-000020-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_8ABE9095142D.md/v1/claims/clm_8ABE9095142Dsubmit a correction